Hypoxic regulation of VEGF, HIF-1(alpha) in coronary collaterals development

Korean Journal of Internal Medicine

Volumn 20, Issue 4, 2005, Pages 295-302

  Ki, Chul Sung ^a   Kyung, Soo Kim ^b   Lee, Sang ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Eulji University School of Medicine   (South Korea)

Author keywords

Collaterals; HIF 1(alpha); VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE SEQUENCE; HUMAN; HYPOXIA; MALE; MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN INDUCTION; ANOXIA; CELL CULTURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; METABOLISM; MIDDLE AGED; MONOCYTE;

ANOXIA; CELLS, CULTURED; COLLATERAL CIRCULATION; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; MONOCYTES; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645830713     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2005.20.4.295     Document Type: Article

References (24)

1. Shima DT, Kuroki M, Deutsch U, Ng YS, Adamis AP, D'Amore PA. Themouse gene for vascular endothelial growth factor genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Bid Chem 271:3877-3883. 1996
2. Levy AP, Levy NS, Loscalzo J, Calderone A, Takahashi N, Yeo KT, Koren G, Colucci WS, Goldberg MA. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 76:758-766, 1995
3. Martin C, Yu AY, Jiang BH, Davis L, Kimberly D, Hohimer AR, Semenza GL. Cardiac hypertrophy in chronically anemicfetal sheep: increased vascularization is associated with increasedmyocardial expression of vascular endothelial growth factor andhypoxia-inducible factor 1. Am J Obstet Gynecol 178:527-534, 1998
4. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757-23763, 1994
5. Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8:588-594, 1998
6. Hogenesch JB, Chan WK, Jackiw VH, Brown RC, Gu YZ, Pray-Grant M, Perdew GH, Bradfield CA. Characterization of a subset of the basichelix-loop-helix- PAS superfamily that interacts with components olthe dioxin signaling pathway. J Biol Chem 272:8581-8593, 1997
7. Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 275:L818-L826, 1998
8. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101:40-50, 1998
9. Schaper W, Buschmann I. Collateral circulation and diabetes. Circulation 99:2224-2226, 1999
10. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelialgrowth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91:2793-2801, 1995
11. Asahara T, Chen D, Tsurumi Y, Keamey M, Rossow S, Passeri J, Symes JF, Isner JM. Accelerated restitution of endothelial integrity andendothelial dependent function after phVEGF165 gene transfer. Circulation 94:3291-3302, 1996
12. van Belle E, Tio FO, Couffinhal T, Maillard L, Passeri J, Isner JM. Stent endothelialization: time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response tocytokine expedition. Circulation 95:438-448, 1997
13. van Belle E, Tio FO, Chen D, Maillard L, Keamey M, Isner JM. Passivationof metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol 29:1371-1379, 1997
14. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342:626-633, 2000
15. Wenger RH, Kvietikova I, Rolfs A, Gassmann M, Marti HH. Hypoxia inducible factor-1(alpha) is regulated at the post m-RNA level. Kidney Int 51:560-563, 1997
16. Kawata H, Yoshida K, Kawamoto A, Kurioka H, Takase E, Sasaki Y, Hatanaka K, Kobayashi M, Ueyarna T, Hashimoto T, Dohi K. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 88:696-704, 2001
17. Ilia R, Carmel S, Gueron M. Patients with coronary collaterals and normalleft ventricular systolic function: clinical, hemodynamic, andangiographic characteristics. Angiology 49:631-635, 1998
18. Kyriakides ZS, Kresmastinos DT, Michelakakis NA, Matsakas EP, Demovelis T, Toutouzas PK. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol 67:687-690, 1991
19. Yarom R, Zirkin H, Stammler G, Rose AG. Human coronary microvessels indiabetes and ischaemia: morphometric study of autopsy material. J Pathol 166:265-270, 1992
20. Morimoto S, Hiasa Y, Hamai K, Wada T, Aihara T, Kataoka Y, Mori H. Influence factors on coronary collateral development. Kokyu To Junkan 37:1103-1107, 1989
21. Melidonis A, Tournis S, Kouvaras G, Baltaretsou E, Hadanis S, Hajissavas I, Tsatsoulis A, Foussas S. Comparison of coronary collateral circulationin diabetic and nondiabetic patients suffering from coronary arterydisease. Clin Cardiol 22:465-471, 1999
22. Waltenberger J. Impaired collateralvessel development in diabetes: potential cellular mechanisms and therapeutic implication. Cardiovasc Res 49:554-560, 2001
23. D'Amore PA, Thompson RW. Mechanisms of angiogenesis. Annu Rev Physiol 49:453-464, 1987
24. Flanagan MF, Aoyagi T, Arnold LW, Maute C, Fujii AM, Currier J, Bergau D, Warren HB, Rakusan K. Effects of chronic heparin administration on coronary vascular adaptation to hypertension and ventricularhypertrophy in sheep. Circulation 100:981-987, 1999